Form 4: RxSight Executive Ilya Goldshleger Executes Stock Option and Sells Shares

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock on September 26 and 30, 2024, according to a Form 4 filing with the SEC.

Summary

• Ilya Goldshleger, Co-President and COO of RxSight, Inc. (RXST), filed a Form 4 with the SEC detailing changes in beneficial ownership.
• On September 26, 2024, Goldshleger exercised stock options to acquire 3,105 shares of common stock at a price of $15.08 per share and sold the same amount of shares at a weighted average price of $49.2926.
• On September 30, 2024, Goldshleger exercised stock options to acquire 3,100 shares of common stock at a price of $15.08 per share.
• On September 30, 2024, Goldshleger sold 1,652 shares at a weighted average price of $48.6919 and 1,448 shares at a weighted average price of $49.3837.
• The sales were executed under a Rule 10b5-1 trading plan adopted on June 3, 2024.
• Following these transactions, Goldshleger directly owns 42,246 shares of common stock and indirectly owns 1,372 shares through a spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports transactions. The use of a 10b5-1 plan suggests pre-planned sales, reducing the likelihood of a negative signal.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely watched by investors for insights into management's perspective on the company's value and future prospects. The use of a 10b5-1 trading plan suggests the sales were pre-planned and intended to avoid any concerns about insider trading.

Stakeholder Impact

• Shareholders may interpret the stock sales as a signal, although the use of a 10b5-1 plan mitigates this concern.
• The transactions have no immediate impact on employees, customers, suppliers, or creditors.

Key Dates